Advertisement

Topics

Remission Noted After 2 Years for Patients with Crohn’s Disease

10:17 EST 17 Feb 2017 | PharmPro

New data shows Stelara (ustekinumab) maintained clinical response and remission after two years of treatment in patients with moderate to severe Crohn’s disease.
Contributed Author: 
Janssen Pharmaceutical Companies

Original Article: Remission Noted After 2 Years for Patients with Crohn’s Disease

NEXT ARTICLE

More From BioPortfolio on "Remission Noted After 2 Years for Patients with Crohn’s Disease"

Quick Search
Advertisement